This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Information Update - Important Information For Canadians: U.S. Meningitis Outbreak

OTTAWA, Oct. 30, 2012 /CNW/ - As the U.S. Food and Drug Administration (FDA) continues to expand its warnings about products made at the New England Compounding Center (NECC), Health Canada would like to advise Canadians that, to date, there have been no Canadian cases reported to Health Canada of fungal meningitis linked to contaminated health products from the NECC.

The NECC facility is not licenced to produce health products for the Canadian market, and Health Canada has not received any information suggesting that any of its products are being imported and sold or used here. In order to help prevent any possible importations of the affected products, Departmental officials are working with Canada Border Services Agency.

The FDA has posted on its web site a list of affected NECC products and a list of U.S. facilities that received products from the NECC. Health Canada is encouraging Canadians who travelled to the U.S. for medical treatments, procedures and surgeries on or after May 21, 2012 to check the U.S. FDA web site to see if their treatment facility may have received NECC products.

If a Canadian visited a facility that appears on the list mentioned above, they should contact the facility to see if they received any NECC products during their treatment. Canadians who may have been treated with an NECC product should immediately consult with a health care provider.

Health Canada continues to be in regular contact with the U.S. FDA to monitor the situation. Should any new safety information arise concerning Canadians or the Canadian market, Health Canada will inform health care professionals and the public.

Complaints involving medical products can be reported to the Health Products and Food Branch Inspectorate by calling the toll-free hotline at 1-800-267-9675, or by writing to:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs